Genea Biomedx
Genea Biomedx creates vitrification and incubation platforms for Assisted Reproductive Technology and In-Vitro Fertilisation (ART, IVF), distributing through one of the world’s biggest pharmaceutical companies. Genea Biomedx IVF tracking market is worth US$20 million. It plans to launch product soon through a major global pharmaceutics partner.
Visit Genea Biomedx >
Planet Innovation
Planet Innovation is a design house which was awarded Australia’s ‘Most Innovative Company’ for five consecutive years. Planet Innovation’s cryogenic cold chain logistics market is US$30 million, alongside adjacent opportunities.
Visit Planet Innovation >
Labcon
Labcon is a large plastic labware manufacturer based in San Francisco, moulding more than 1.4 billion consumables each year. Its bio-preservation market is estimated at US$200 million, with US$40 million of that being in 2ml vials.
Visit Labcon >Bluechiip Customers
Bluechiip has several reference sites where Bluechiip is operating:
- Institute of Molecular Bioscience, CRC Autism, Brisbane, Queensland, AUS
- HUDSON Institute, Translational Research Facility and Cell Therapy platform, Melbourne, AUS
- Centre for Disease and Control, Beijing, CN
- Plataforma Biobanco Pulmonar CIBERES, Mallorca, SPN
